Blizard Jeffrey 4

What Happened

• Jeffrey Blizard, a director of SANUWAVE Health, received a grant/award of 5,524 derivative securities on June 30, 2026. The Form 4 reports the acquisition price as $0.00 (total reported value $0). A filing footnote states the options were vested at the grant date.
• This was an award/acquisition (not a sale). The transaction represents compensation or an equity-based grant rather than an open-market purchase.

Key Details

• Transaction date: 2026-06-30; Form 4 filed: 2026-07-02 (appears timely).
• Reported quantity: 5,524 derivative shares/options acquired at $0.00 (total $0 reported).
• Shares owned after transaction: not specified in the filing.
• Footnote: Options were vested at the grant date (immediate vesting).
• Filing type: Form 4 (insider reporting); transaction coded as an award/grant (A).

Context

• This was a derivative grant (options) that vested immediately per the footnote. Immediate vesting means the award became exercisable at grant, but the Form 4 does not indicate any exercise, sale, or exercise price in this report.
• Awards and option grants are common components of director compensation; they do not necessarily signal a buy/sell decision by the insider.